Change theme to redChange theme to blueChange theme to greenChoose your color
 

Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@mail.mil



COMBINATIONS OF GENE DELETIONS FOR LIVE ATTENUATED SHIGELLA VACCINE STRAINS

Shigella vaccine strains whose primary attenuating feature is deletion of the virG(icsA) gene and additional two or more deletions in setAB(shET1), senA(shET2), senB(shET2-2), stxAB, and msbB2 genes. Thus, the vaccine strain will have three or more deletions in the identified genes, will be safer, and will reduce or eliminate symptoms of fever and diarrhea in humans. The following specific vaccine strains have been constructed: WRSS3 (.DELTA.senA, .DELTA.senB, .DELTA.virG, .DELTA.msbB2), WRSf2G15 (.DELTA.virG, .DELTA.setAB, .DELTA.senA, .DELTA.senB, .DELTA.msbB2), and WRSd5 (.DELTA.virG, .DELTA.stxAB, .DELTA.senA, .DELTA.senB, .DELTA.msbB2).


Docket:WRAIR 06-76

Publication/Issued No.:9,320,789

Publication/Issue Date:2016-04-26

Categories: Vaccine

More Detail:Visit USPTO.GOVExternal link

Lab:WRAIR

Inventor(s):VENKATASEN, ET AL


For Licensing Opportunities, please contact the ORTA at USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@mail.mil
 

iSalute

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at:
usarmy.detrick.medcom-usamrmc.list.webmaster@mail.mil or by telephone at (301)619-2736